Cipher Pharmaceuticals Inc. (TSX:CPH)
13.30
-0.20 (-1.48%)
Nov 20, 2025, 3:59 PM EST
Cipher Pharmaceuticals Revenue
Cipher Pharmaceuticals had revenue of $12.83M USD in the quarter ending September 30, 2025, with 23.75% growth. This brings the company's revenue in the last twelve months to $50.06M, up 89.17% year-over-year. In the year 2024, Cipher Pharmaceuticals had annual revenue of $33.36M with 57.66% growth.
Revenue (ttm)
$50.06M
Revenue Growth
+89.17%
P/S Ratio
4.84
Revenue / Employee
$10.01M
Employees
5
Market Cap
337.42M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.36M | 12.20M | 57.66% |
| Dec 31, 2023 | 21.16M | 487.00K | 2.36% |
| Dec 31, 2022 | 20.68M | -1.27M | -5.78% |
| Dec 31, 2021 | 21.94M | 336.00K | 1.56% |
| Dec 31, 2020 | 21.61M | -844.00K | -3.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| Knight Therapeutics | 413.85M |
Cipher Pharmaceuticals News
- 13 days ago - Cipher Pharmaceuticals Inc (CPHRF) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 13 days ago - Q3 2025 Cipher Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
- 13 days ago - Cipher Pharmaceuticals Inc. (CPH:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - CIPHER PHARMACEUTICALS INC Profit Climbs In Q3, Beats Estimates - Nasdaq
- 6 weeks ago - Halvio Capital Q3 2025 Position Updates - Seeking Alpha
- 3 months ago - Cipher Pharmaceuticals Inc. (CPHRF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue - Benzinga
- 6 months ago - Cipher Pharmaceuticals Inc. (CPHRF) Q1 2025 Earnings Call Transcript - Seeking Alpha